196 related articles for article (PubMed ID: 35203352)
1. Identification of Dysregulated Expression of G Protein Coupled Receptors in Endocrine Tumors by Bioinformatics Analysis: Potential Drug Targets?
Suteau V; Munier M; Ben Boubaker R; Wery M; Henrion D; Rodien P; Briet C
Cells; 2022 Feb; 11(4):. PubMed ID: 35203352
[TBL] [Abstract][Full Text] [Related]
2. G Protein-coupled Receptors in Radioiodine-refractory Thyroid Cancer in the Era of Precision Medicine.
Suteau V; Seegers V; Munier M; Ben Boubaker R; Reyes C; Gentien D; Wery M; Croué A; Illouz F; Hamy A; Rodien P; Briet C
J Clin Endocrinol Metab; 2021 Jul; 106(8):2221-2232. PubMed ID: 34000025
[TBL] [Abstract][Full Text] [Related]
3. G Protein-Coupled Receptors as Targets for Approved Drugs: How Many Targets and How Many Drugs?
Sriram K; Insel PA
Mol Pharmacol; 2018 Apr; 93(4):251-258. PubMed ID: 29298813
[TBL] [Abstract][Full Text] [Related]
4. Identification of key genes and pathways of thyroid cancer by integrated bioinformatics analysis.
Liu L; He C; Zhou Q; Wang G; Lv Z; Liu J
J Cell Physiol; 2019 Dec; 234(12):23647-23657. PubMed ID: 31169306
[TBL] [Abstract][Full Text] [Related]
5. GPCRs show widespread differential mRNA expression and frequent mutation and copy number variation in solid tumors.
Sriram K; Moyung K; Corriden R; Carter H; Insel PA
PLoS Biol; 2019 Nov; 17(11):e3000434. PubMed ID: 31765370
[TBL] [Abstract][Full Text] [Related]
6. Transcriptome Profiling of Dysregulated GPCRs Reveals Overlapping Patterns across Psychiatric Disorders and Age-Disease Interactions.
Monfared RV; Alhassen W; Truong TM; Gonzales MAM; Vachirakorntong V; Chen S; Baldi P; Civelli O; Alachkar A
Cells; 2021 Oct; 10(11):. PubMed ID: 34831190
[TBL] [Abstract][Full Text] [Related]
7. Identification of hub genes in thyroid carcinoma to predict prognosis by integrated bioinformatics analysis.
Pan Y; Wu L; He S; Wu J; Wang T; Zang H
Bioengineered; 2021 Dec; 12(1):2928-2940. PubMed ID: 34167437
[TBL] [Abstract][Full Text] [Related]
8. MiR-375: A prospective regulator in medullary thyroid cancer based on microarray data and bioinformatics analyses.
Shi L; Zhao SM; Luo Y; Zhang AW; Wei LH; Xie ZY; Li YY; Ma W
Pathol Res Pract; 2017 Nov; 213(11):1344-1354. PubMed ID: 29033189
[TBL] [Abstract][Full Text] [Related]
9. Systematic analysis of G protein-coupled receptor gene expression in adrenocorticotropin-independent macronodular adrenocortical hyperplasia identifies novel targets for pharmacological control of adrenal Cushing's syndrome.
Assie G; Louiset E; Sturm N; René-Corail F; Groussin L; Bertherat J; Thomas M; Lefebvre H; Feige JJ; Clauser E; Chabre O; Cherradi N
J Clin Endocrinol Metab; 2010 Oct; 95(10):E253-62. PubMed ID: 20660048
[TBL] [Abstract][Full Text] [Related]
10. Identification and interaction analysis of key miRNAs in medullary thyroid carcinoma by bioinformatics analysis.
Zhang L; Lu D; Liu M; Zhang M; Peng Q
Mol Med Rep; 2019 Sep; 20(3):2316-2324. PubMed ID: 31322209
[TBL] [Abstract][Full Text] [Related]
11. Identification and Characterization of Neuropeptides and Their G Protein-Coupled Receptors (GPCRs) in the Cowpea Aphid
Li X; Du L; Jiang XJ; Ju Q; Qu CJ; Qu MJ; Liu TX
Front Endocrinol (Lausanne); 2020; 11():640. PubMed ID: 33042012
[TBL] [Abstract][Full Text] [Related]
12. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
Yang C; Gong A
Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
[No Abstract] [Full Text] [Related]
13. Illuminating the Onco-GPCRome: Novel G protein-coupled receptor-driven oncocrine networks and targets for cancer immunotherapy.
Wu V; Yeerna H; Nohata N; Chiou J; Harismendy O; Raimondi F; Inoue A; Russell RB; Tamayo P; Gutkind JS
J Biol Chem; 2019 Jul; 294(29):11062-11086. PubMed ID: 31171722
[TBL] [Abstract][Full Text] [Related]
14. Identification of potential biomarkers and drugs for papillary thyroid cancer based on gene expression profile analysis.
Qu T; Li YP; Li XH; Chen Y
Mol Med Rep; 2016 Dec; 14(6):5041-5048. PubMed ID: 27779685
[TBL] [Abstract][Full Text] [Related]
15. The landscape of cancer-rewired GPCR signaling axes.
Arora C; Matic M; Bisceglia L; Di Chiaro P; De Oliveira Rosa N; Carli F; Clubb L; Nemati Fard LA; Kargas G; Diaferia GR; Vukotic R; Licata L; Wu G; Natoli G; Gutkind JS; Raimondi F
Cell Genom; 2024 May; 4(5):100557. PubMed ID: 38723607
[TBL] [Abstract][Full Text] [Related]
16. Identification of differentially expressed genes between triple and non-triple-negative breast cancer using bioinformatics analysis.
Zhai Q; Li H; Sun L; Yuan Y; Wang X
Breast Cancer; 2019 Nov; 26(6):784-791. PubMed ID: 31197620
[TBL] [Abstract][Full Text] [Related]
17. Two GEO MicroRNA Expression Profile Based High-Throughput Screen to Identify MicroRNA-31-3p Regulating Growth of Medullary Thyroid Carcinoma Cell by Targeting RASA2.
Jiang M; Shi X; Zhu H; Wei W; Li J
Med Sci Monit; 2019 Jul; 25():5170-5180. PubMed ID: 31298226
[TBL] [Abstract][Full Text] [Related]
18. Identification of potential drugs for diffuse large b-cell lymphoma based on bioinformatics and Connectivity Map database.
Luo B; Gu YY; Wang XD; Chen G; Peng ZG
Pathol Res Pract; 2018 Nov; 214(11):1854-1867. PubMed ID: 30244948
[TBL] [Abstract][Full Text] [Related]
19. Identification of Potential Biomarkers with Diagnostic Value in Pituitary Adenomas Using Prediction Analysis for Microarrays Method.
Peng H; Deng Y; Wang L; Cheng Y; Xu Y; Liao J; Wu H
J Mol Neurosci; 2019 Nov; 69(3):399-410. PubMed ID: 31280474
[TBL] [Abstract][Full Text] [Related]
20. Multiple analyses of G-protein coupled receptor (GPCR) expression in the development of gefitinib-resistance in transforming non-small-cell lung cancer.
Kuzumaki N; Suzuki A; Narita M; Hosoya T; Nagasawa A; Imai S; Yamamizu K; Morita H; Suzuki T; Okada Y; Okano HJ; Yamashita JK; Okano H; Narita M
PLoS One; 2012; 7(10):e44368. PubMed ID: 23144692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
